Mirvetuximab soravtansine (IMGN853), an antibody-drug conjugate (ADC), integrates the cytotoxic agent DM4 with the humanized monoclonal antibody M9346A through a covalent bond. This compound targets folate receptor 1 (FOLR1) with specificity and exerts a
CAS Number:
[1453084-37-1]
Target:
Others|||Antibody-Drug Conjugates (ADCs)
T77825
* VAT and and shipping costs not included. Errors and price changes excepted